MMWR Surveill Summ 74(2):1
Mild side effects reported during or after glutathione IV infusions include: Nausea and vomiting occur in some individuals, particularly at higher doses or faster infusion rates
These disorders may also manifest in individuals with naturally shifted cycles, such as those with delayed sleep phase syndrome (night owls who struggle to sleep and wake early) or advanced sleep phase syndrome (early birds who tire and wake much earlier than typical)
In September 2023, the FDA added BPC-157 to its Category 2 list of bulk drug substances under its Interim Policy on Compounding, meaning 503A compounding pharmacies and 503B outsourcing facilities are barred from using it in compounded preparations
There is a bidirectional relationship between psychological stress and infertility
Bilanicov, D., Salis, A., Ninham, B